With twenty years of experience providing lymphoedema care at a large teaching hospital in Sydney, I’ve had plenty of time to spot what isn’t working in current systems. Even though research in lymphoedema continues to grow, day-to-day treatment decisions are still made with a limited evidence base.
Lymbase was created in response to that gap. It’s a clinic support tool that helps therapists collect and present assessment data consistently, using a dataset defined through rigorous research. The aim is to create a common language for clinical dialogue, comparison, and research—and reduce unnecessary variation in care.
One major reason the evidence base remains limited is that change isn’t measured and reported consistently, whether in the clinic or in the research. That makes shared learning difficult and can leave patients navigating a “trial and error” approach. Every clinic visit generates useful assessment data, but much of its potential remains untapped. With patient consent, de-identified routine-care data can help build stronger evidence.
While Lymbase aims to create efficiencies and improve workflows many experienced clinicians have developed their own hard-won systems to track progress. Change can feel disruptive. But our hope is simple: that patients better understand their condition and treatment response and that new therapists – and their patients – don’t have to rely on unnecessary experiential learning to find what works.
Ultimately, we need stronger evidence to guide which treatment approaches to apply, when to adjust them, and when to step them back. Lymbase has been designed by clinicians to help build that future.
Dr Robyn Sierla – Founder of Lymbase
A secure cloud-based clinical decision support system for lymphoedema, Lymbase has been designed for clinicians, by clinicians.
Dr Robyn Sierla (PhD, MApplSc, BAppSc)
Senior Lymphoedema Therapist | Clinician-Researcher | Founder, Lymbase®
Dr Robyn Sierla is a senior lymphoedema therapist at Royal Prince Alfred Hospital (Sydney Local Health District) with over 20 years of clinical experience. She is a leading clinician-researcher passionate about improving care for those living with chronic oedema.
Robyn holds a PhD from the University of Sydney, where her research focused on digital health integration in clinical practice. She is the founder of Lymbase®, a clinical support system designed to enable precision care in lymphoedema management. She is also an Honorary Clinician Lecturer at the University of Sydney and the Scientific Convenor for the 2026 Australasian Lymphology Association Conference.
Robyn has received multiple grants and fellowships, including from Sydney Health Partners, the Agency for Clinical Innovation, and the NSW Department of Industry. She has also consulted with the NSW Government on lymphoedema service provision and actively mentors emerging clinician-researchers.
Mythili Baker
Executive – Data and AI Leader, Aware Super | Co-founder Lymbase®
Mythili Baker is an accomplished technology and data leader with extensive experience driving strategic innovation and transformation in complex organisations. She currently serves as Head of Data & AI at Aware Super, where she leads the development and execution of enterprise‑wide data, analytics, and artificial intelligence strategies to support organisational growth and innovation.
Prior to her current role, Mythili held senior leadership positions at Altis Consulting, one of Australia’s leading data and analytics firms – including Regional Managing Director for NSW and Queensland and Head of Innovation, where she specialised in product management, stakeholder engagement, business development, and delivering high‑impact data‑driven solutions.
Mythili is also a co‑founder of Lymbase and continues to contribute as a strategic consultant to support the platform’s growth and impact in chronic oedema care. In this capacity, she brings deep expertise in technology strategy, digital platforms, and innovation to help drive better clinician tools and patient outcomes.